Invitae’s study, in collaboration with The Outer Banks Hospital, found universal hereditary cancer genetic testing for all breast cancer patients aligns with the American Society of Breast Surgeons’ guidelines. It showed that 91.4% of patients took up the testing, which improved patient outcomes, optimized resources and informed treatment plans. The study also supports the idea that genetic testing should be adopted as a standard in breast cancer care.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
